Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19

NCT04327505 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped Futility, change of disease due to virus mutations and/or vaccination

Conditions

SARS (Severe Acute Respiratory Syndrome)
Cytokine Storm
ARDS, Human
COVID-19
Sars-CoV2
Acute Respiratory Failure

Interventions

DRUG: Hyperbaric oxygen

Sponsor

Karolinska Institutet

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]